This article has been updated to include share price and details.

NEW YORK, Nov. 4 (GenomeWeb News) - Shares in Bruker BioSciences were down 6.27 percent at $3.13 in late-afternoon trade--six cents above their 52-week high--despite modest third-quarter revenue.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.